GIUSTI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.791
EU - Europa 4.237
AS - Asia 2.503
SA - Sud America 323
AF - Africa 66
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.963
Nazione #
US - Stati Uniti d'America 5.743
PL - Polonia 1.595
RU - Federazione Russa 1.198
SG - Singapore 723
CN - Cina 576
HK - Hong Kong 416
IT - Italia 399
VN - Vietnam 311
BR - Brasile 265
SE - Svezia 245
IE - Irlanda 236
KR - Corea 184
FI - Finlandia 127
FR - Francia 124
DE - Germania 119
IN - India 76
GB - Regno Unito 74
AU - Australia 38
JP - Giappone 36
JO - Giordania 34
ID - Indonesia 33
AR - Argentina 28
BE - Belgio 24
BD - Bangladesh 21
TR - Turchia 19
CI - Costa d'Avorio 18
NL - Olanda 18
CA - Canada 17
IQ - Iraq 17
UA - Ucraina 17
ES - Italia 13
CH - Svizzera 12
MX - Messico 12
PK - Pakistan 12
ZA - Sudafrica 12
CO - Colombia 8
DO - Repubblica Dominicana 8
UZ - Uzbekistan 8
DZ - Algeria 7
NG - Nigeria 7
RO - Romania 7
MA - Marocco 6
CL - Cile 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
IL - Israele 5
KE - Kenya 5
SA - Arabia Saudita 5
LT - Lituania 4
LV - Lettonia 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
AI - Anguilla 1
AO - Angola 1
AT - Austria 1
BJ - Benin 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
LI - Liechtenstein 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
Totale 12.963
Città #
Warsaw 1.593
Santa Clara 1.216
Ashburn 723
Fairfield 536
Singapore 478
Hong Kong 361
Chandler 287
Woodbridge 243
Dublin 236
Seattle 225
Cambridge 217
Houston 201
San Jose 194
Seoul 179
Beijing 171
Ann Arbor 169
Wilmington 168
Ho Chi Minh City 103
Lawrence 84
Altamura 79
Princeton 70
Hefei 67
Buffalo 66
Lauterbourg 63
Munich 63
Hanoi 60
Los Angeles 60
Florence 58
The Dalles 58
Helsinki 54
Boston 52
Council Bluffs 49
Shanghai 43
New York 39
Melbourne 36
Dallas 35
Mumbai 34
Boardman 32
Medford 31
San Diego 31
São Paulo 31
Tokyo 28
Jakarta 27
Paris 27
Phoenix 26
Dong Ket 24
Milan 24
Moscow 23
Brussels 22
Clifton 22
Turku 22
Abidjan 18
Kent 18
Pune 16
Redondo Beach 16
Rome 15
Andover 13
Da Nang 13
Haiphong 13
Jacksonville 13
Orem 13
Bern 12
Falls Church 12
Norwalk 12
Rio de Janeiro 12
Frankfurt am Main 11
Lappeenranta 10
London 10
Yubileyny 10
Izmir 8
Renton 8
Brooklyn 7
Denver 7
Johannesburg 7
Lyon 7
Stockholm 7
Toronto 7
Abuja 6
Baghdad 6
Bengaluru 6
Durham 6
Hillsboro 6
Manchester 6
Miami 6
Salerno 6
Tashkent 6
West Jordan 6
Amsterdam 5
Atlanta 5
Chicago 5
Falkenstein 5
Hải Dương 5
Karachi 5
Langhorne 5
Montreal 5
Naples 5
Ninh Bình 5
Porto Alegre 5
Tianjin 5
Washington 5
Totale 9.160
Nome #
Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up. 333
Management impact: effects on quality of life and prognosis in MEN1 329
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens 327
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database 327
MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors 320
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". 312
Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. 305
Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. 301
Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology 296
Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update 273
Thyroid cancer: current molecular perspectives. 267
Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters 263
The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome 261
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. 254
Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity. 239
When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism 230
Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications 213
Blomstrand’s chondrodysplasia 212
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database 203
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients 203
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. 201
A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. 191
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. 189
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes 188
Circulating MicroRNAs as Biomarkers of Osteoporosis and Fragility Fractures 182
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization. 182
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. 179
Hereditary hyperparathyroidism syndromes. 178
Calcolosi renale recidivante: una nnuova mutazione del gene codificante il recettore del calcio( CASR) 178
Calcifediol: mechanisms of action 172
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) 171
Genetic predictors of skeletal outcomes in healthy fertile women: The Bonturno Study. 170
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. 170
Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report. 164
Osteonecrosis of the Jaw In A Patient With Rheumatoid Artritis Treated With An Oral Aminobisphosphonate: A Clinical Case Report 163
Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story. 163
CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy 161
Sarcomatoid carcinoma of the kidney in a MEN1 patient: Case report and genetic profile. 161
Endocrine sequelae of hematopoietic stem cell transplantation: Effects on mineral homeostasis and bone metabolism 156
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders. 153
Prevalence of Osteoporosis and Risk Factors For Bone Demineralization In Italy: First Results From the Firmo Study 151
Molecular diagnosis of parathyroid carcinoma: a reality in the near future. 150
Carcinoma mammario e osteoporosi: risultati preliminari di uno studio fiorentino 149
Variazioni molecolari del gene codificante la fosfatasi alcalina: correlazione con la massa ossea (BMD) e i markers biochimici di turnover osseo 149
Un particolare caso di iperparatiroidismo primitivo giovanile 149
Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs 149
Calcifediol: Why, When, How Much? 148
Soft tissue postraumatic calcifications associated with a new FGF23 gene mutation: clinicopathological and molecular genetic study 148
[Left laparoscopic adrenalectomy for pheochromocytoma in MEN 2B: case report]. 146
A New Fgf23 Gene Polymorphism: Possible Role In the Pathogenesis of the Development of Extraskeletal Calcifications? 144
Un nuovo caso di sclerosi ossea: osteopochilosi 143
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens: response to comments by Chen et al. 141
ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia 141
Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study 140
Association between vitamin D and bisphenol A levels in an elderly Italian population: results from the InCHIANTI study 139
Fracture unit: a (possible) model of implementation in Italy. 134
Efficacy of Cinacalcet Therapy In Patients Affected By Primary Hyperparathyroidism Associated To Multiple Endocrine Neoplasia Syndrome Type 1 (men1): Preliminary Results of the Florentine Study 133
Genotype-Phenotype Correlation Analyses in an Italian MEN1 Series. MEN1 Gene Mutational Performed at the Center for Hereditary Endocrine Tumors of Florence 130
THE EFFECTS OF RH-PTH (1-34) ON BONE METABOLISM IN HYPOPARATHYROID PATIENTS 128
Pancreatic neuroendocrine tumors in MEN1 patients: difference in post-operative complications and tumor progression between major and minimal pancreatic surgeries 123
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture 122
Tricho-rhino-phalangeal syndrome: role of different methods of measuring bone density 122
Genetic Determinants of inherited endocrine tumors: do they have a direct role in bone metabolism regulation and osteoporosis? 121
Prevalenza dell'osteoporosi e dei principale fattori di rischio nella popolazione italiana: risultiati del BOne tour 2012 120
Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 117
CALCIFICATIONS IN DERMATOMYOSITIS: A CLINICAL CASE WITH AN ALTERATION OF PHOSPHATE HOMEOSTASIS, CARRIER OF A NEW FGF23 GENE MUTATION 117
A NOVEL TISSUE-NONSPECIFIC ISOENZYME OF ALKALINE PHOSPHATASE (TNSALP) MUTATION IN ADULT PATIENT WITH LOW BONE MASS AND MUSCULOSKELETAL SYMPTOMS 113
Osteogenesis Imperfecta: Realization of A Multidisciplinar Network To Improve Information, Expertise and Resources 107
Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? 104
Multiple Endocrine Neoplasia Type 1 97
RETROSPECTIVE COHORT STUDY OF PATIENTS AFFECTED BY CHRONIC HYPOPARATHYROIDISM 72
Serums miR-24-3p and miR-1301-3p as potential biomarkers in MEN1 syndrome 33
Evolving our understanding of vitamin D, periostin levels and cardiovascular risk in the elderly: a cross sectional study 9
Osteopetrosis: Pathogenesis, Clinical Management, and Emerging Therapies 6
Totale 13.035
Categoria #
all - tutte 33.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.885


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 0 54
2021/2022453 15 41 30 21 23 15 21 38 18 28 74 129
2022/20231.178 117 265 39 86 83 200 140 58 134 11 23 22
2023/2024574 12 50 80 22 23 81 35 216 10 14 21 10
2024/20253.490 124 347 239 529 1.107 417 48 217 162 57 132 111
2025/20263.374 459 499 282 306 394 160 483 180 194 271 80 66
Totale 13.035